# OnCo record adze-biotechnology (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/adze-biotechnology/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "adze-biotechnology" ;
  schema:name "Adze Biotechnology"@en ;
  schema:alternateName "Adze Biotechnology Inc"@en, "Adze Biotechnology Australia Pty Ltd"@en, "ADZE"@en ;
  schema:description "Adze Biotechnology is developing viruses engineered to infect and kill cancer cells while carrying immune-boosting drugs into the tumour. Its first product, Adze1.C, is in an early trial in melanoma that has spread."@en ;
  schema:url <https://onco.cc/companies/adze-biotechnology/>, <https://adzebiotech.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://adzebiotech.com/>, <https://adzebiotech.com/news/>, <https://clinicaltrials.gov/study/NCT07086105> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/tnbc/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/oncolytic-virus/> .